Knowledge is power.
The Kellis IP Weekly
Since living in Brazil from 2021-2024 as the USPTO’s Intellectual Property Attaché for Brazil, Argentina, Paraguay, Uruguay, Guyana, and Suriname, Mr. Kellis has published the Kellis IP Weekly to help interested parties stay informed regarding intellectual property developments in Brazil and the surrounding region. If you have questions or concerns about any of the developments described in the Kellis IP Weekly and how those developments might impact your business, please contact Kellis IP.
Search the Kellis IP Weekly
The Kellis IP Weekly: Issue 10.5
INPI Releases Study on Patenting Scenario Surrounding Monoclonal Antibodies for Breast Cancer Treatment: The study, coordinated by INPI and conducted by the Technical Group for Intelligence in Industrial Property under the Interministerial Group for Intellectual Property (GIPI), evaluates patent applications related to the monoclonal antibodies trastuzumab and pertuzumab (which are costly for Brazil’s universal health system, SUS, to acquire) . . .
Click below to read more and see additional headlines.
The Kellis IP Weekly: Issue 10.4
Courts Prevent Retroactive Application of New Patent Appeal Guidelines: Decisions from the 9th, 12th, and 25th Federal Courts of Rio de Janeiro have all concluded that INPI’s new patent appeal guidelines, which went into force on April 2, cannot be applied retroactively. In the 9th Federal Court decision . . .
Click below to read more and see additional headlines.
The Kellis IP Weekly: Issue 10.1
Brazil Ranks 50th in Global Innovation Index: WIPO’s 2024 Global Innovation Index lists Brazil one spot below its ranking last year, but the country still holds the top spot within Latin America and the Caribbean. Five years ago, Brazil was ranked at 66th, making it one of the top climbers since 2019. The country also . . .
Click below to read more and see additional headlines.
The Kellis IP Weekly: Issue 9.1
INPI Announces Anti-Counterfeiting Directory for GIs: INPI’s National Directory for Combatting Counterfeiting, which previously contained information pertinent only to trademarks, has been expanded to include GI-related information. GI owners may now include . . .
Click below to see more headlines.